Cite

HARVARD Citation

    Tagliamento, M. et al. (2018). Afatinib and Erlotinib in the treatment of squamous-cell lung cancer. Expert opinion on pharmacotherapy. pp. 2055-2062. [Online]. 
  
Back to record